Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Syndax Pharmaceuticals (SNDX) Return on Equity (2016 - 2021)

Historic Return on Equity for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Q3 2021 value amounting to 0.1%.

  • Syndax Pharmaceuticals' Return on Equity rose 3700.0% to 0.1% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.1%, marking a year-over-year increase of 3700.0%. This contributed to the annual value of 0.76% for FY2024, which is 3500.0% down from last year.
  • As of Q3 2021, Syndax Pharmaceuticals' Return on Equity stood at 0.1%, which was up 3700.0% from 0.18% recorded in Q2 2021.
  • In the past 5 years, Syndax Pharmaceuticals' Return on Equity ranged from a high of 0.1% in Q3 2021 and a low of 1.52% during Q4 2019
  • For the 5-year period, Syndax Pharmaceuticals' Return on Equity averaged around 0.77%, with its median value being 0.6% (2017).
  • Its Return on Equity has fluctuated over the past 5 years, first tumbled by -9700bps in 2017, then skyrocketed by 11500bps in 2020.
  • Quarter analysis of 5 years shows Syndax Pharmaceuticals' Return on Equity stood at 0.6% in 2017, then plummeted by -115bps to 1.29% in 2018, then decreased by -18bps to 1.52% in 2019, then skyrocketed by 76bps to 0.37% in 2020, then surged by 74bps to 0.1% in 2021.
  • Its Return on Equity was 0.1% in Q3 2021, compared to 0.18% in Q2 2021 and 0.23% in Q1 2021.